Artelo Biosciences Probability of Future Stock Price Finishing Over 0.0056
| ARTLWDelisted Stock | USD 0.01 0.00 0.00% |
Artelo |
Artelo Biosciences Target Price Odds to finish over 0.0056
The tendency of Artelo Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.01 | 90 days | 0.01 | about 92.59 |
Based on a normal probability distribution, the odds of Artelo Biosciences to move above the current price in 90 days from now is about 92.59 (This Artelo Biosciences probability density function shows the probability of Artelo Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon Artelo Biosciences has a beta of -9.6. This suggests as returns on its benchmark rise, returns on holding Artelo Biosciences are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Artelo Biosciences is expected to outperform its benchmark. In addition to that Artelo Biosciences has an alpha of 3.8478, implying that it can generate a 3.85 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Artelo Biosciences Price Density |
| Price |
Predictive Modules for Artelo Biosciences
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Artelo Biosciences. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Artelo Biosciences Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Artelo Biosciences is not an exception. The market had few large corrections towards the Artelo Biosciences' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Artelo Biosciences, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Artelo Biosciences within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 3.85 | |
β | Beta against Dow Jones | -9.6 | |
σ | Overall volatility | 0.01 | |
Ir | Information ratio | 0.08 |
Artelo Biosciences Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Artelo Biosciences for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Artelo Biosciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Artelo Biosciences is not yet fully synchronised with the market data | |
| Artelo Biosciences has some characteristics of a very speculative penny stock | |
| Artelo Biosciences has a very high chance of going through financial distress in the upcoming years | |
| Artelo Biosciences has accumulated 63 K in total debt. Artelo Biosciences has a current ratio of 0.4, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Note, when we think about Artelo Biosciences' use of debt, we should always consider it together with its cash and equity. | |
| Net Loss for the year was (10.08 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Artelo Biosciences has accumulated about 457.33 K in cash with (8.01 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.23, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Artelo Biosciences Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Artelo Stock often depends not only on the future outlook of the current and potential Artelo Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Artelo Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 2.8 M | |
| Cash And Short Term Investments | 17.5 M |
Artelo Biosciences Technical Analysis
Artelo Biosciences' future price can be derived by breaking down and analyzing its technical indicators over time. Artelo Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Artelo Biosciences. In general, you should focus on analyzing Artelo Stock price patterns and their correlations with different microeconomic environments and drivers.
Artelo Biosciences Predictive Forecast Models
Artelo Biosciences' time-series forecasting models is one of many Artelo Biosciences' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Artelo Biosciences' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Artelo Biosciences
Checking the ongoing alerts about Artelo Biosciences for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Artelo Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Artelo Biosciences is not yet fully synchronised with the market data | |
| Artelo Biosciences has some characteristics of a very speculative penny stock | |
| Artelo Biosciences has a very high chance of going through financial distress in the upcoming years | |
| Artelo Biosciences has accumulated 63 K in total debt. Artelo Biosciences has a current ratio of 0.4, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Note, when we think about Artelo Biosciences' use of debt, we should always consider it together with its cash and equity. | |
| Net Loss for the year was (10.08 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Artelo Biosciences has accumulated about 457.33 K in cash with (8.01 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.23, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Consideration for investing in Artelo Stock
If you are still planning to invest in Artelo Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Artelo Biosciences' history and understand the potential risks before investing.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |